Suppr超能文献

成年肝移植受者的超大剂量液体输注:一项单中心观察性研究。

Ultra-massive fluid transfusion in adult liver transplant recipients: A single center observational study.

作者信息

Slifirski Hugh, Raykateeraroj Nattaya, Armellini Angelica, Hazard Riley, Zalcman Jordan, Zhao Junyan, Tran Zac, Le Peter, Zhang Wendell, Fink Michael, Perini Marcos Vinicius, Koshy Anoop N, Lee Dong-Kyu, Weinberg Laurence

机构信息

Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.

Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

PLoS One. 2025 Jun 17;20(6):e0325829. doi: 10.1371/journal.pone.0325829. eCollection 2025.

Abstract

INTRODUCTION

Patients undergoing liver transplantation may require large volumes of fluid to maintain hemodynamic stability and treat coagulopathy. This study aimed to determine the prevalence of ultra-massive fluid transfusion and to examine its association with clinical outcomes. We defined an ultra-massive fluid transfusion a priori as a transfusion volume of >20 liters of crystalloids, colloids, blood and blood products administered intraoperatively and within the first 24 hours postoperatively.

METHODS

This single-center retrospective observational study included all adult patients who underwent an orthotopic liver transplant and received an ultra-massive fluid transfusion. The primary aim was to determine the prevalence of ultra-massive fluid transfusion in patients undergoing liver transplantation. Secondary objectives included evaluating the effect of the total volume of fluid and packed red blood cell transfusions on postoperative complications, mechanical ventilation hours, intensive care unit and hospital length of stay, and mortality.

RESULTS

Of the 844 liver transplantation procedures, 81 (9.6%) required an ultra-massive fluid transfusion with a median transfusion volume of 36.8 liters (IQR: 31.2-48.7). Each additional liter of fluid administered during surgery was associated with an additional stay of 0.47 days in intensive care (95%CI: 0.18-0.76, p = 0.003). Each additional unit of packed red blood cells administered during surgery was associated with an additional 12.8 hours of mechanical ventilation (95%CI: 3.12-22.43, p = 0.014) and 1.0 additional day in intensive care (95%CI: 0.27-1.79, p = 0.012). Neither ultra-massive fluid transfusion nor packed red blood cell transfusions were associated with increased complications.

CONCLUSION

Approximately one in ten liver transplantation patients required an ultra-massive fluid transfusion. While ultra-massive fluid transfusion was associated with prolonged recovery, it was not associated with an increased risk of complications or mortality.

摘要

引言

接受肝移植的患者可能需要大量液体来维持血流动力学稳定并治疗凝血功能障碍。本研究旨在确定超大量液体输注的发生率,并探讨其与临床结局的关联。我们预先将超大量液体输注定义为术中及术后24小时内输注超过20升晶体液、胶体液、血液及血液制品。

方法

这项单中心回顾性观察性研究纳入了所有接受原位肝移植并接受超大量液体输注的成年患者。主要目的是确定肝移植患者中超大量液体输注的发生率。次要目标包括评估液体总量和红细胞悬液输注量对术后并发症、机械通气时间、重症监护病房和住院时间以及死亡率的影响。

结果

在844例肝移植手术中,81例(9.6%)需要超大量液体输注,中位输注量为36.8升(四分位间距:31.2 - 48.7)。手术期间每额外输注1升液体,在重症监护病房的住院时间就会增加0.47天(95%置信区间:0.18 - 0.76,p = 0.003)。手术期间每额外输注1单位红细胞悬液,机械通气时间会增加12.8小时(95%置信区间:3.12 - 22.43,p = 0.014),在重症监护病房的住院时间会增加1.0天(95%置信区间:0.27 - 1.79,p = 0.012)。超大量液体输注和红细胞悬液输注均与并发症增加无关。

结论

大约十分之一的肝移植患者需要超大量液体输注。虽然超大量液体输注与恢复时间延长有关,但与并发症或死亡率增加无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a4/12173374/0e575d978561/pone.0325829.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验